Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IONTEC is a medical technology company specializing in the development and manufacture of interventional cardiology and peripheral vascular products. The company is best known for its expertise in balloon catheter technology, particularly Percutaneous Transluminal Coronary Angioplasty (PTCA) balloons. Following its acquisition by B. Braun Melsungen AG in 2007, IONTEC's operations were integrated into B. Braun's Interventional Vascular Diagnostics division. Its product portfolio includes high-performance balloon catheters such as the SeQuent and SeQuent Please series, which are used to treat arterial stenosis and facilitate stent delivery. The company continues to operate as a key innovation hub for B. Braun's vascular intervention business in Barcelona.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IONTEC.